1 active not recruiting, 1 terminated. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Active not recruiting 1, Terminated 1 |
Follow Chronic Lymphoid Leukemia: new trials by email Literature Review of Chronic Lymphoid Leukemia trials Research Report on Chronic Lymphoid Leukemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ibrutinib Monotherapy Versus Fixed-duration Venetoclax Plus Obinutuzumab Versus Fixed-duration Ibrutinib Plus Venetoclax in Patients With Previously Untreated Chronic Lymphocytic Leukaemia (CLL) Ibrutinib, Venetoclax, Obinutuzumab - Chronic Lymphoid Leukemia | Phase 3 | Active not recruiting | German CLL Study Group | 897 | 2021-03-01 | 2026-04-30 |
| The Effect of 25-OH-Vitamin-D3 Substitution in Patients With Malignant and Immune-hematologic Diseases Cholecalciferol, oleum neutralicum - Chronic Lymphoid Leukemia | Phase 3 | Terminated | Semmelweis University | 31 | 2012-01-01 | 2020-07-16 |
Leukemia, B-Cell (2)
Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2) · Immune System Diseases (2) · Immunoproliferative Disorders (2) · Leukemia (2) · Leukemia, Lymphoid (2) · Lymphatic Diseases (2) · Lymphoproliferative Disorders (2) · Neoplasms (2) · Neoplasms by Histologic Type (2)
Cholecalciferol (1) · ibrutinib (1) · obinutuzumab (1) · venetoclax (1)
German CLL Study Group (1) · Semmelweis University (1)
Austria (1) · Belgium (1) · Denmark (1) · Finland (1) · Germany (1) · Hungary (1) · Ireland (1) · Israel (1) · Italy (1) · Netherlands (1) · Norway (1) · Spain (1) · Sweden (1) · Switzerland (1)
Istvan Takacs, MD, PhD (1) · Othman Al-Sawaf, Dr. med. (1)
2019 (1)